| Filed On | Filing |
|---|---|
| 21 Sep 2026 |
Form 4: Smith Trent N., CFO
Received 15,000 shares as a grant or award |
| 08 Sep 2026 |
Form 4: Klemp Walter V, Director
Received 13,000 shares as a grant or award |
| 08 Sep 2026 |
Form 4: Bisson Lori, Director
Received 13,000 shares as a grant or award |
| 08 Sep 2026 |
Form 4: Hauser Bradley, CEO and President
Received 27,000 shares as a grant or award |
| 13 Aug 2025 |
Form 4: Klemp Walter V, Director
Disposed of 8,773 Option (Right to buy) (Disposition to Issuer) |
| 13 Aug 2025 |
Form 4: Hauser Bradley, CEO and President
Disposed of 45,000 Option (Right to buy) (Disposition to Issuer) |
| 13 Aug 2025 |
Form 4: Capelli Christopher, Director
Disposed of 3,750 Option (Right to buy) (Disposition to Issuer) |
| 13 Aug 2025 |
Form 4: Bisson Lori, Director
Disposed of 65,542 Option (Right to buy) (Disposition to Issuer) |
| 13 Aug 2025 |
Form 4: Smith Trent N., CFO
Disposed of 32,655 Option (Right to buy) (Disposition to Issuer) |
| 26 Jul 2024 |
Form 4: Robins David Andrew, Director
Acquired 103,990 Warrant (Right to buy) (Open Market Purchase) ($104) |
| 24 Jun 2024 |
Form 4: Smith Trent N., CFO
Granted 228,087 Option (Right to buy) |
| 24 Jun 2024 |
Form 4: Klemp Walter V, Director
Granted 175,452 Option (Right to buy) |
| 24 Jun 2024 |
Form 4: Bisson Lori, Director
Granted 377,221 Option (Right to buy) |
| 20 Jun 2024 |
Form 4: Hauser Bradley, CEO and President
Granted 900,000 Option (Right to buy) |
| 20 Jun 2024 |
Form 4: BioStar Ventures III, L.p., 10% owner
Acquired 1,088,000 Warrant to Purchase Common Stock (Open Market Purchase) ($30.5K) |
Loading...